Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z004454 | — |
No adverse event; a patient who was administered improperly stored VARIVAX; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender. The patient's medical history, concurrent condition, concomitant therapies were not reported. On an unknown date, the vaccine Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), 0.5 mL/dose, #Z004454, expiration date: 13-Feb-2027 was temperature excursion (TE) from -12.6C / -14°C up to -10°C (worst-case scenario, no TE assessment) for 0 Hours 45 Minutes 0 Seconds (worst-case scenario, no TE assessment). The previous temperature excursion was unknown. Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) was unable to be assessed using in-house stability data due to data logger discrepancies. On 28-Jul-2025, this vaccine was vaccinated to the patient for prophylaxis (strength, and route of administration were not provided) (Product storage error). No symptoms reported. No additional AE details reported.
Sterile Diluent